ModivCare ROE 2010-2024 | MODV
Current and historical return on equity (ROE) values for ModivCare (MODV) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| ModivCare ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2024-03-31 | $-0.22B | $0.14B | -145.10% |
| 2023-12-31 | $-0.20B | $0.16B | -98.67% |
| 2023-09-30 | $-0.21B | $0.16B | -80.31% |
| 2023-06-30 | $-0.23B | $0.16B | -75.68% |
| 2023-03-31 | $-0.04B | $0.35B | -10.26% |
| 2022-12-31 | $-0.03B | $0.36B | -9.00% |
| 2022-09-30 | $-0.06B | $0.35B | -15.62% |
| 2022-06-30 | $-0.04B | $0.38B | -9.64% |
| 2022-03-31 | $-0.03B | $0.38B | -6.66% |
| 2021-12-31 | $-0.01B | $0.37B | -1.74% |
| 2021-09-30 | $0.02B | $0.40B | 5.35% |
| 2021-06-30 | $0.07B | $0.41B | 15.76% |
| 2021-03-31 | $0.04B | $0.42B | 9.49% |
| 2020-12-31 | $0.03B | $0.41B | 8.48% |
| 2020-09-30 | $0.03B | $0.41B | 8.19% |
| 2020-06-30 | $0.00B | $0.36B | 0.00% |
| 2020-03-31 | $0.01B | $0.33B | 2.78% |
| 2019-12-31 | $-0.00B | $0.32B | -1.12% |
| 2019-09-30 | $-0.02B | $0.40B | -5.65% |
| 2019-06-30 | $-0.02B | $0.39B | -6.01% |
| 2019-03-31 | $-0.03B | $0.32B | -8.75% |
| 2018-12-31 | $-0.03B | $0.31B | -7.14% |
| 2018-09-30 | $0.03B | $0.38B | 8.10% |
| 2018-06-30 | $0.04B | $0.37B | 9.96% |
| 2018-03-31 | $0.05B | $0.40B | 13.78% |
| 2017-12-31 | $0.04B | $0.34B | 11.98% |
| 2017-09-30 | $0.08B | $0.38B | 22.51% |
| 2017-06-30 | $0.07B | $0.36B | 19.90% |
| 2017-03-31 | $0.07B | $0.36B | 20.61% |
| 2016-12-31 | $0.08B | $0.38B | 22.45% |
| 2016-09-30 | $0.07B | $0.31B | 19.93% |
| 2016-06-30 | $0.06B | $0.33B | 18.18% |
| 2016-03-31 | $0.06B | $0.35B | 18.65% |
| 2015-12-31 | $0.07B | $0.37B | 20.49% |
| 2015-09-30 | $0.01B | $0.31B | 3.10% |
| 2015-06-30 | $0.02B | $0.32B | 6.25% |
| 2015-03-31 | $0.02B | $0.31B | 8.64% |
| 2014-12-31 | $0.02B | $0.22B | 10.94% |
| 2014-09-30 | $0.02B | $0.18B | 9.68% |
| 2014-06-30 | $0.02B | $0.18B | 12.68% |
| 2014-03-31 | $0.02B | $0.16B | 12.82% |
| 2013-12-31 | $0.02B | $0.15B | 14.21% |
| 2013-09-30 | $0.02B | $0.15B | 15.07% |
| 2013-06-30 | $0.02B | $0.14B | 13.60% |
| 2013-03-31 | $0.01B | $0.13B | 10.06% |
| 2012-12-31 | $0.01B | $0.12B | 6.91% |
| 2012-09-30 | $0.01B | $0.12B | 7.06% |
| 2012-06-30 | $0.01B | $0.12B | 8.18% |
| 2012-03-31 | $0.02B | $0.11B | 15.09% |
| 2011-12-31 | $0.02B | $0.11B | 16.79% |
| 2011-09-30 | $0.02B | $0.10B | 18.70% |
| 2011-06-30 | $0.02B | $0.10B | 20.77% |
| 2011-03-31 | $0.02B | $0.09B | 20.87% |
| 2010-12-31 | $0.02B | $0.09B | 28.48% |
| 2010-09-30 | $0.03B | $0.08B | 33.78% |
| 2010-06-30 | $0.03B | $0.08B | 38.66% |
| 2010-03-31 | $0.02B | $0.07B | 40.00% |
| 2009-12-31 | $0.02B | $0.06B | 39.62% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.368B | $2.756B |
| ModivCare Inc. is a technology-enabled healthcare services company. It provides a suite of integrated supportive care solutions for public and private payors and their patients. ModivCare Inc., formerly known as The Providence Service Corporation, is based in DENVER. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $124.209B | 15.59 |
| Cencora (COR) | United States | $47.206B | 18.40 |
| ICON (ICLR) | Ireland | $26.298B | 24.83 |
| DiDi Global (DIDIY) | China | $21.580B | 0.00 |
| Avantor (AVTR) | United States | $15.025B | 22.12 |
| CochLear (CHEOY) | Australia | $14.104B | 0.00 |
| Revvity (RVTY) | United States | $13.324B | 23.37 |
| Natera (NTRA) | United States | $13.153B | 0.00 |
| Medpace Holdings (MEDP) | United States | $12.518B | 41.19 |
| Viatris (VTRS) | United States | $12.466B | 3.73 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $10.906B | 0.00 |
| Charles River Laboratories (CRL) | United States | $10.900B | 20.87 |
| Solventum (SOLV) | United States | $9.041B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.666B | 0.00 |
| HealthEquity (HQY) | United States | $7.278B | 46.73 |
| Organon (OGN) | United States | $5.359B | 5.08 |
| Bausch + Lomb (BLCO) | Canada | $5.253B | 21.03 |
| Doximity (DOCS) | United States | $5.103B | 35.74 |
| PACS (PACS) | United States | $4.437B | 0.00 |
| Life Times (LTH) | United States | $3.659B | 38.33 |
| Sotera Health (SHC) | United States | $3.400B | 16.68 |
| Surgery Partners (SGRY) | United States | $3.113B | 28.48 |
| GoodRx Holdings (GDRX) | United States | $2.900B | 110.43 |
| Agilon Health (AGL) | United States | $2.681B | 0.00 |
| Progyny (PGNY) | United States | $2.462B | 42.39 |
| NovoCure (NVCR) | Jersey | $2.052B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.013B | 7.98 |
| Premier (PINC) | United States | $1.950B | 8.34 |
| BrightSpring Health Services (BTSG) | United States | $1.819B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.647B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.566B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $1.388B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.141B | 0.00 | |
| CareDx (CDNA) | United States | $0.732B | 0.00 |
| Embecta (EMBC) | United States | $0.721B | 4.91 |
| GeneDx Holdings (WGS) | United States | $0.717B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.673B | 7.14 |
| InnovAge Holding (INNV) | United States | $0.646B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.599B | 0.00 |
| Sharecare (SHCR) | United States | $0.497B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.437B | 11.45 |
| Enhabit (EHAB) | United States | $0.428B | 42.70 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.427B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.370B | 0.00 |
| DocGo (DCGO) | United States | $0.314B | 17.17 |
| LifeMD (LFMD) | United States | $0.289B | 0.00 |
| MultiPlan (MPLN) | United States | $0.236B | 0.00 |
| Beauty Health (SKIN) | United States | $0.221B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.217B | 0.00 |
| Biodesix (BDSX) | United States | $0.196B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.189B | 0.00 |
| So-Young (SY) | China | $0.108B | 52.00 |
| Pono Capital Two (PTWO) | United States | $0.068B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.046B | 0.00 |
| NeueHealth (NEUE) | United States | $0.042B | 5.72 |
| IceCure Medical (ICCM) | Israel | $0.034B | 0.00 |
| Oncology Institute (TOI) | United States | $0.033B | 0.00 |
| Nutex Health (NUTX) | United States | $0.028B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.026B | 0.00 |
| OncoCyte (OCX) | United States | $0.023B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.023B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.022B | 0.00 |
| KindlyMD (KDLY) | $0.017B | 0.00 | |
| BIMI Holdings (BIMI) | United States | $0.015B | 0.00 |
| TRxADE HEALTH (MEDS) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| ISpecimen (ISPC) | United States | $0.005B | 0.00 |
| DermTech (DMTK) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.004B | 0.00 |
| OpGen (OPGN) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Assure Holdings (IONM) | United States | $0.002B | 0.00 |